Ovol2 induces mesenchymal–epithelial transition via targeting ZEB1 in osteosarcoma

References

• MorrowJJKhannaCOsteosarcoma genetics and epigenetics: emerging biology and candidate therapiesCrit Rev Oncog2015203–417319726349415
   PubMedGoogle Scholar
• MoriarityBSOttoGMRahrmannEPA sleeping beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasisNat Genet201547661562425961939
   PubMed Web of Science ®Google Scholar
• LamplotJDDenduluriSQinJThe current and future therapies for human osteosarcomaCurr Cancer Ther Rev201391557726834515
   PubMedGoogle Scholar
• JollyMKBoaretoMHuangBImplications of the hybrid epithelial/mesenchymal phenotype in metastasisFront Oncol2015515526258068
   PubMed Web of Science ®Google Scholar
• KahlertUDJosephJVKruytFAEEMT and MET-related processes in non-epithelial tumors: importance for disease progression, prognosis and therapeutic opportunitiesMol Oncol201711786087728556516
   PubMed Web of Science ®Google Scholar
• StoneRCPastarIOjehNEpithelial–mesenchymal transition in tissue repair and fibrosisCell Tissue Res2016365349550627461257
   PubMed Web of Science ®Google Scholar
• PradellaDNaroCSetteCGhignaCEMT and stemness: flexible processes tuned by alternative splicing in development and cancer progressionMol Cancer2017161828137272
   PubMed Web of Science ®Google Scholar
• YangHZhangYZhouZJiangXShenASnail-1 regulates VDR signaling and inhibits 1,25(OH)-D(3) action in osteosarcomaEur J Pharmacol20116702–334134621963453
   PubMed Web of Science ®Google Scholar
• ShariliASAllenSSmithKPriceJMcGonnellIMSnail2 promotes osteosarcoma cell motility through remodelling of the actin cytoskeleton and regulates tumor developmentCancer Lett2013333217017923352643
   PubMed Web of Science ®Google Scholar
• OkamuraHYoshidaKHanejiTNegative regulation of TIMP1 is mediated by transcription factor TWIST1Int J Oncol200935118118619513566
   PubMed Web of Science ®Google Scholar
• ZhouYHuangZWuSZangXLiuMShiJMiR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWISTJ Exp Clin Cancer Res2014331224468065
   PubMed Web of Science ®Google Scholar
• ShenAZhangYYangHXuRHuangGOverexpression of ZEB1 relates to metastasis and invasion in osteosarcomaJ Surg Oncol2012105883083422213004
   PubMed Web of Science ®Google Scholar
• FeiDZhaoKYuanHXingJZhaoDMicroRNA-187 exerts tumor-suppressing functions in osteosarcoma by targeting ZEB2Am J Cancer Res20166122859286828042505
   PubMed Web of Science ®Google Scholar
• LeeBVillarreal-PonceAFallahiMTranscriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cellsDev Cell2014291475824735878
   PubMed Web of Science ®Google Scholar
• ItoTTsujiGOhnoFActivation of the OVOL1-OVOL2 axis in the hair bulb and in pilomatricomaAm J Pathol201618641036104326873447
   PubMed Web of Science ®Google Scholar
• AueAHinzeCWalentinKA grainy head-like 2/Ovo-like 2 pathway regulates renal epithelial barrier function and lumen expansionJ Am Soc Nephrol201526112704271525788534
   PubMed Web of Science ®Google Scholar
• YeGDSunGBJiaoPOVOL2, an inhibitor of WNT signaling, reduces invasive activities of human and mouse cancer cells and is down-regulated in human colorectal tumorsGastroenterology20161503659671.e61626619963
   PubMed Web of Science ®Google Scholar
• JollyMKJiaDBoaretoMCoupling the modules of EMT and stemness: a tunable ‘stemness window’ modelOncotarget2015628251612517426317796
   PubMedGoogle Scholar
• WuRSHongJJWuJFOVOL2 antagonizes TGF-beta signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasisOncotarget2017824394013941628455959
   PubMedGoogle Scholar
• MooneySMParsanaPHernandezJRThe presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptorJ Cell Biochem2015116111512325160502
   PubMed Web of Science ®Google Scholar
• FuHQiLChenLHeYZhangNGuoHExpression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinomaOnco Targets Ther201695963597327729805
   PubMed Web of Science ®Google Scholar
• WangZHLiZHuMOvol2 gene inhibits the epithelial-to-mesenchymal transition in lung adenocarcinoma by transcriptionally repressing Twist1Gene20176001827884772
   PubMed Web of Science ®Google Scholar
• TaniaMKhanMAFuJEpithelial to mesenchymal transition inducing transcription factors and metastatic cancerTumour Biol20143587335734224880591
   PubMedGoogle Scholar
• ZhangPSunYMaLZEB1: at the crossroads of epithelial–mesenchymal transition, metastasis and therapy resistanceCell Cycle201514448148725607528
   PubMed Web of Science ®Google Scholar
• LiuZSunBQiLLiHGaoJLengXZinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transitionCancer Sci2012103481382022212097
   PubMed Web of Science ®Google Scholar
• LiuCPanCCaiYWangHInterplay between long noncoding RNA ZEB1-AS1 and miR-200s regulates osteosarcoma cell proliferation and migrationJ Cell Biochem201711882250226028075045
   PubMed Web of Science ®Google Scholar
• ItoTTsujiGOhnoFNakaharaTUchiHFurueMPotential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinomaMod Pathol201730791992728339425
   PubMed Web of Science ®Google Scholar
• UnezakiSHoraiRSudoKIwakuraYItoSOvol2/Movo, a homologue of Drosophila ovo, is required for angiogenesis, heart formation and placental development in miceGenes Cells200712677378517573777
   PubMed Web of Science ®Google Scholar
• MackayDRHuMLiBRheaumeCDaiXThe mouse Ovol2 gene is required for cranial neural tube developmentDev Biol20062911385216423343
   PubMed Web of Science ®Google Scholar
• WatanabeKVillarreal-PonceASunPMammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressorDev Cell2014291597424735879
   PubMed Web of Science ®Google Scholar
• KitazawaKHikichiTNakamuraTOVOL2 maintains the transcriptional program of human corneal epithelium by suppressing epithelial-to-mesenchymal transitionCell Rep20161561359136827134177
   PubMed Web of Science ®Google Scholar
• ChenJWangLMatyuninaLVHillCGMcDonaldJFOverexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cellsGynecol Oncol2011121120020521277012
   PubMed Web of Science ®Google Scholar